Xylem Affirms Q3 Adj EPS Guidance of $1.42-$1.47 vs $1.46 Est; Affirms Q3 Sales Guidance of $2.300B vs $2.316B Est

Loading news article.

Xylem Affirms Q3 Adj EPS Guidance of $1.42-$1.47 vs $1.46 Est; Affirms Q3 Sales Guidance of $2.300B vs $2.316B Est | WAPE

Article summary